Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma07/10/2023 - 06/30/2028 (PI)
NIH/National Cancer Institute5R01CA275015-03
The Boston University - UCLA Lung Cancer Biomarker Characterization Center09/01/2022 - 07/31/2027 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Cancer Institute5U2CCA271898-04
EXCAMP -- effect of military exposures on airway gene expression and molecular modifiers of lung cancer among military personnel07/01/2024 - 06/30/2026 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. USU Federal Med Sch
Sequencing of nasal RNA from individuals at high risk for lung cancer01/01/2023 - 12/31/2025 (PI)
Inova Health Care Services
mRNA expression sequencing analysis of nasal swabs from workers exposed to electronic waste processing in Accra, Ghana07/15/2025 - 09/20/2025 (Subcontract PI)
Westat, Inc. NIH NCI75N91022D00006
Data sample and extraction, sequencing, and QC on samples from the GWAS replication lung cancer study09/01/2024 - 08/31/2025 (PI)
NIH/National Cancer Institute
The American Lung Association (ALA) Lung Health Cohort06/15/2019 - 06/30/2025 (Subcontract PI)
Northwestern University NIH NHLBI5U01HL146408-06
The Boston University Clinical and Transitional Science Institute04/15/2020 - 03/31/2025 (Key Person)
PI:
Megan H. Bair-Merritt, MD, MSCENIH/National Center for Advancing Translational Sciences5UL1TR001430-09
Transitions from Impaired Respiratory Health to Lung Disease01/01/2020 - 06/30/2024 (Subcontract PI)
Northwestern University NIH NHLBI5R01HL122477-07
Exploring the potential role of IL33 in bronchiectasis08/01/2023 - 02/29/2024 (PI)
Sanofi US Services Inc.
Showing 10 of 22 results.
Show All Results
Impact of smoking and its cessation on systemic and airway immune activation07/01/2022 - 12/31/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA5R01DA042685-05
Improving Outcomes After Lung Cancer Surgery01/01/2022 - 12/31/2023 (PI)
Ellison Foundation
mRNA expression sequencing analysis of nasal swabs from workers exposed to electronic waste processing in Accra, Ghana (CAS: 10821)09/21/2022 - 09/20/2023 (PI)
NIH/National Cancer Institute75N91022P00843
Molecular and Imaging biomarkers for early lung cancer detection in the setting of Indeterminate Pulmonary Nodules09/23/2016 - 08/31/2023 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Cancer Institute5R01CA210360-06
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers03/01/2019 - 03/01/2023 (Co-Investigator)
PI:
Ehab Billatos, MDJohnson & Johnson
The Boston University-UCLA Lung Cancer Biomarker Development Lab09/20/2016 - 09/30/2022 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Cancer Institute3U01CA214182-05S1
Integrated molecular, cellular and imaging characterization of screen-detected lung cancer09/16/2015 - 08/31/2021 (Multi-PI)
PI:
Marc Lenburg, PhDUniversity of California, Los Angeles NIH NCI3U01CA196408-05S1
Study BET inhibitors in COPD12/18/2017 - 02/28/2019 (PI)
AstraZeneca AB
Integrative Omics to Discover Molecular Determinants of COPD06/01/2016 - 05/31/2018 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Heart, Lung, and Blood Institute4R01HL118542-04
Molecular biomarkers of airway and lung linking COPD and Lung Cancer09/15/2011 - 07/31/2016 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Cancer Institute5R01CA164783-04
Integrative Omics to Discover Molecular Determinants of COPD08/15/2013 - 05/31/2016 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Heart, Lung, and Blood Institute5R01HL118542-03
Validation of a Genomic Biomarker of Responses to Environmental Tobacco Smoke08/08/2011 - 06/30/2015 (Multi-PI)
PI:
Marc Lenburg, PhDNIH/National Institute of Environmental Health Sciences5R01ES020425-02